68Ga-FAP-2286

N/A

Report date: 2026/04/24 20:01:59

Base Information

Drug Name68Ga-FAP-2286
Drug Alias Name68Gallium-Fibroblast Activation Protein-2286Gallium-68 labelled (68Ga-) FAP-228668Ga-FAP-228668-Ga-FAP-2286
ClassificationRadiation-emitting products > Radioactive diagnostic agentDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[5] 
Mechanisms of ActionPositron-emission tomography enhancersRadionuclide imaging enhancersFibroblast activation protein alpha modulators
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesItaly +[6] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator Companies3B Pharmaceuticals GmbH
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CaliforniaOdense University HospitalNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm MetastasisBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A